It's very interesting to watch the goings-on of OSL from the sidelines. It will be interesting too to see how it all unfolds, and how quickly. The case history would make a great article for a journalist familiar with how biotech stuff works.
Read this somewhere recently:
Q: How can you make money in biotechs?
A: Don't buy biotechs.
That's funny! But a tad extreme. But I do think OSL sounds super-risky based management's lack of communication about the FDA and CM Mark progress. And threatening people with law suits sounds like a low and desperate act. Yet Chris Roberts accepted a directorship... as I said, it's very interesting to watch...from afar!
It's very interesting to watch the goings-on of OSL from the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
0.005(0.47%) |
Mkt cap ! $20.23M | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.08 | $1.07 | $498.0K | 465.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 531 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 8531 | 2 |
View Market Depth
| Last trade - 10.35am 01/08/2025 (20 minute delay) ? |
| OSL (ASX) Chart |